Ticker League

Net Profit Margin for Vertex Pharmaceuticals (VRTX)

As of · Reported

Metric

TTM

35.4%

YoY change

+37.60pp

Trough year (2009)

-628.7%

Peak year (2018)

68.8%

Net Profit Margin history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: 32.7%

Net Profit Margin change chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: +37.60pp

Net Profit Margin history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

  • 202532.7%+37.60pp
  • 2024-4.9%-41.54pp
  • 202336.7%-0.52pp
  • 202237.2%+6.28pp
  • 202130.9%-12.78pp
  • 202043.7%+15.43pp
  • 201928.3%-40.54pp
  • 201868.8%+58.22pp
  • 201710.6%+17.17pp
  • 2016-6.6%+47.48pp
  • 2015-54.1%+73.18pp
  • 2014-127.2%-90.53pp
  • 2013-36.7%-29.71pp
  • 2012-7.0%-9.11pp
  • 20112.1%+528.45pp
  • 2010-526.3%+102.35pp
  • 2009-628.7%-366.68pp
  • 2008-262.0%-65.41pp
  • 2007-196.6%-100.99pp
  • 2006-95.6%+30.81pp
  • 2005-126.4%+35.42pp
  • 2004-161.8%+122.74pp
  • 2003-284.6%-217.16pp
  • 2002-67.4%-27.89pp
  • 2001-39.5%+11.22pp
  • 2000-50.8%+15.80pp
  • 1999-66.6%+7.99pp
  • 1998-74.5%-29.34pp
  • 1997-45.2%+255.55pp
  • 1996-300.8%-203.47pp
  • 1995-97.3%-7.49pp
  • 1994-89.8%-96.96pp
  • 19937.2%+230.85pp
  • 1992-223.7%-64.31pp
  • 1991-159.4%+27.58pp
  • 1990-187.0%—

Net Profit Margin values are taken from Vertex Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Net Profit Margin at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported net margin is 35.4%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual net margin for Vertex Pharmaceuticals (VRTX) came in at 32.74% – expanded 37.6 percentage points year-over-year.

Across the available history, net margin reached its high of 68.80% in 2018 and its low of -628.70% in 2009.

Vertex Pharmaceuticals Net Profit Margin by Year

Vertex Pharmaceuticals Net Profit Margin 2025: 32.7%

2025's net margin for Vertex Pharmaceuticals came in at 32.74%, expanded 37.6 percentage points from 2024.

Vertex Pharmaceuticals Net Profit Margin 2024: -4.9%

Vertex Pharmaceuticals posted net margin of -4.86% in 2024, contracted 41.5 percentage points from 2023.

Vertex Pharmaceuticals Net Profit Margin 2023: 36.7%

In 2023, Vertex Pharmaceuticals reported net margin of 36.68%, contracted 0.5 percentage points from 2022.

Vertex Pharmaceuticals Net Profit Margin 2022: 37.2%

Vertex Pharmaceuticals net margin in 2022 was 37.20%, expanded 6.3 percentage points from 2021.

Vertex Pharmaceuticals Net Profit Margin 2021: 30.9%

Vertex Pharmaceuticals net margin in 2021 was 30.92%.

See more financial history for Vertex Pharmaceuticals (VRTX).

Sector peers by Net Profit Margin

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest net margin

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends paid by this company.